Liu et al. [84] demonstrated the contribution of POX/PRODH in the progression of non-small cell lung cancer (NSCLC) through increased expression of pro-inflammatory cytokines that are associated with poor prognoses in NSCLC patients. This evidence concerns the gene PRODH and non-small cell lung carcinoma.